About Stratatech Corp
Stratatech Corp is a company based in United States founded in 2000 was acquired by Mallinckrodt Pharmaceuticals in August 2016. Stratatech Corp has raised $3.68 million across 23 funding rounds from investors including Mallinckrodt Pharmaceuticals, HHS and National Cancer Institute. The company has 47 employees. Stratatech Corp operates in a competitive market with competitors including Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.
- Headquarter United States
- Employees 47
- SectorsHealthcare
- Website stratatechcorp.com
- Social LinkedIn
- Acquired by Mallinckrodt Pharmaceuticals (Aug 2016)
- Total Equity Funding$3.68M (USD)
in 23 rounds
- Latest Funding Round$26M (USD), Grant
Sep 2018
- InvestorsMallinckrodt Pharmaceuticals
& 7 more
- Employee Count47
- Acquired byMallinckrodt Pharmaceuticals
(Aug 2016)
Funding Insights of Stratatech Corp
Stratatech Corp has successfully raised a total of $3.68M across 23 strategic funding rounds. The most recent funding activity was a Grant round of $26 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.68M
- Total Rounds 23
- Last Round Grant — $26M
- First Round $2M
(Aug 2003)
- Investors Count 7
Latest 10 of 23 funding rounds of Stratatech Corp with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $26M | Grant | – | – | |
| Dec 2016 | $5.23M | Grant | – | – | |
| Jun 2012 | $1.62M | Grant | – | – | |
| Oct 2011 | $4.6M | Grant | – | – | |
| Jan 2011 | $499,877 | Grant | – | – | |
| Nov 2010 | $3.5M | Grant | – | – | |
| Jul 2010 | $3.46M | Grant | – | – | |
| Apr 2010 | $1.16M | Grant | – | – | |
| Apr 2010 | $1.19M | Grant | – | – | |
| Apr 2010 | $3M | Seed | – | – | – |
8 investors in total: 8 institutional.
Investors in Stratatech Corp
Stratatech Corp has secured backing from 8 investors, including institutional investors. Prominent investors backing the company include Mallinckrodt Pharmaceuticals, HHS and National Cancer Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Research and health information on diabetes and kidney diseases are provided by NIDDK. | 1950 | niddk.nih.gov | United States | |
- | – | niaid.nih.gov | - | |
Cancer research is conducted and supported by the institute. | – | cancer.gov | Bethesda, United States | |
Research and information on aging are provided by this institute. | – | nia.nih.gov | Bethesda, United States | |
Basic research is supported to advance medical sciences. | – | nigms.nih.gov | Bethesda, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Specialty pharmaceutical products and diagnostic imaging agents are manufactured. | 1867 | mallinckrodt.com | St. Louis, United States |
Investor details for Stratatech Corp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Stratatech Corp
4 dated milestones of Stratatech Corp across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Stratatech Corp is founded.
- Funding First funding round of $2.0M.
- Exit Acquired by Mallinckrodt Pharmaceuticals.
- Funding Latest funding round, Grant, of $26.0M.
Competitors of Stratatech Corp
Stratatech Corp operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ilyapharma.se | 2016 | Uppsala, Sweden | $4.02M | – | Biological drugs for skin and mucosa wound treatment are developed. | |
| qbiotics.com | 2000 | Brisbane, Australia | $98.07M | – | Small molecules from plant extracts are developed for medical applications. | |
| mediwound.com | 2001 | Yavne, Israel | $18M | – | Enzymatic therapies for tissue repair and regeneration are developed. | |
| resolution-tx.com | 2017 | Edinburgh, United Kingdom | $119.88M | 6 | Macrophage cell therapies are developed for inflammatory and liver diseases. | |
| sanuwave.com | 2005 | Alpharetta, United States | $1.43M | 38 | Noninvasive devices and biologics for wound healing are developed. | |
| tempothera.com | 2014 | San Diego, United States | $20.17M | – | Regenerative biomaterials for wounds are developed using particle technology. | |
| aurealistherapeutics.com | 2015 | Basel, Switzerland | $22.04M | – | Provider of cell & gene therapy platforms for chronic wounds, cancer, and inflammatory diseases | |
| stemsontx.com | 2019 | San Diego, United States | $22.5M | – | Stem cell-based therapy for hair growth is developed using iPSCs. | |
| kalocyte.com | 2016 | St. Louis, United States | $1.1M | – | Nanotechnology-based red blood cell substitutes are developed. | |
| tissueregenix.com | 2006 | Swillington, United Kingdom | – | 7 | Developer of regenerative medical devices by using cell technology |
Detailed competitors of Stratatech Corp
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stratatech Corp
Complete news archive for Stratatech Corp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Stratatech Corp
10 companies that operate in the same segment as Stratatech Corp (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Stratatech Corp
Stratatech Corp was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Stratatech Corp is headquartered in United States.
Stratatech Corp is a funded company, having raised a total of $3.68M across 23 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Aug 2003.
Stratatech Corp has 47 employees.
Stratatech Corporation is a regenerative medicine company focused on the commercialization of unique, proprietary skin substitute products for therapeutic and research uses. The company flagship product StrataGraft skin tissue is a temporary wound cover that promotes wound healing by the patients own cells and improve the wound bed to receive autografts The Biomedical Advanced Research and Development Authority has awarded a contract valued at up to 247M for development of StrataGraft skin tissue.
Stratatech Corp's top competitors include Ilya Pharma, SanuWave and QBiotics.
Stratatech Corp has 8 investors. Key investors include Mallinckrodt Pharmaceuticals, HHS, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and NIAID.
Yes. Stratatech Corp was acquired by Mallinckrodt Pharmaceuticals in August 2016.